S
Stockadora
Back to Insider Trading View Full Company Profile

KALV

HEALTHY

KalVista Pharmaceuticals, Inc.

CIK: 0001348911

Strong Sell (90% confidence)

Last activity: 2 days ago

Financial Metrics

As of Apr 30, 2025 (10-K)

Net Income -$29.12M
Total Cash $131.62M

Insider Roster (5 total, 5 active)

Insider Buys Sells Net Value Holdings
Palleiko Benjamin L
CHIEF EXECUTIVE OFFICER
 		0 4 -$385K
428,286 shares
$6.72M
Audhya Paul K.
CHIEF MEDICAL OFFICER
 		0 2 -$116K
131,831 shares
$1.77M
Yea Christopher
CHIEF DEVELOPMENT OFFICER
 		0 2 -$97K
223,508 shares
$3.01M
Piekos Brian
Chief Financial Officer
 		0 1 -$60K
10,529 shares
$142K
Sweeny Nicole
Chief Commercial Officer
 		0 1 -$51K
39,728 shares
$534K

Recent Transactions

SELL Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER)

3,354 shares @ $15.70

$53K

Feb 12, 2026

Conviction: | View SEC Filing →
SELL Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER)

7,294 shares @ $16.51

$120K

Dec 8, 2025

Conviction: | View SEC Filing →
SELL Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER)

10,940 shares @ $13.45

$147K

Nov 24, 2025

Conviction: | View SEC Filing →
SELL Audhya Paul K. (CHIEF MEDICAL OFFICER)

5,296 shares @ $13.45

$71K

Nov 24, 2025

Conviction: | View SEC Filing →
SELL Piekos Brian (Chief Financial Officer)

4,471 shares @ $13.45

$60K

Nov 24, 2025

Conviction: | View SEC Filing →
SELL Yea Christopher (CHIEF DEVELOPMENT OFFICER)

4,331 shares @ $13.45

$58K

Nov 24, 2025

Conviction: | View SEC Filing →
SELL Sweeny Nicole (Chief Commercial Officer)

3,813 shares @ $13.45

$51K

Nov 24, 2025

Conviction: | View SEC Filing →
SELL Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER)

4,466 shares @ $14.48

$65K

Nov 18, 2025

Conviction: | View SEC Filing →
SELL Audhya Paul K. (CHIEF MEDICAL OFFICER)

3,075 shares @ $14.48

$45K

Nov 18, 2025

Conviction: | View SEC Filing →
SELL Yea Christopher (CHIEF DEVELOPMENT OFFICER)

2,683 shares @ $14.48

$39K

Nov 18, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.